Safety and Immunologic Activity of Multiple Infusions of APN401
Phase of Trial: Phase I
Latest Information Update: 11 Jul 2018
At a glance
- Drugs APN 401 (Primary)
- Indications Colorectal cancer; Pancreatic cancer; Solid tumours
- Focus Adverse reactions
- 05 Jun 2018 Results (n=16) presented at the 54th Annual Meeting of the American Society of Clinical Oncology.
- 30 May 2018 According to an Apeiron Biologics media release, data from this trial will be presented at the American Society of Clinical Oncology (ASCO) Annual Meeting 2018.
- 29 Mar 2018 Planned End Date changed from 1 Apr 2018 to 1 Oct 2018.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History